| TELIX PHARMACEUTICALS LTD |
| Australien |
| Gesundheit |
| AU000000TLX2 / A2H7JK |
| T3X (Frankfurt) |
| FRA:T3X, ETR:T3X, T3X:GR |
| - |
| https://telixpharma.com/ |
|
Telix Pharmaceuticals Limited is a global, commercial-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceuticals for oncology. Headquartered..
>Volltext.. |
| 1746.41 Mio. EUR |
| 1926.49 Mio. EUR |
| 574.99 Mio. EUR |
| 36.72 Mio. EUR |
| 9.25 Mio. EUR |
| 0.03 EUR |
| 354.7 Mio. EUR |
| 175.68 Mio. EUR |
| 17.74 Mio. EUR |
| 0.69 |
| 43.72% |
| -69.63% |
| - |
| - |
| - |
| - |
| TELIX |
| 18.02.26 |
|
||||
|